Department of Health Informatics, Graduate School of Medicine & School of Public Health, Kyoto University Medical Administration Division, Aillis, Inc.,
Director of Pharmaceutical Director of Pharmaceutical Affairs General Affairs Division Pharmaceutical Safety and Environmental Health Bureau Ministry of Health, Labour and Welfare
Mitsui Fudosan Co.,Ltd. Executive Manager, Planning Group Kashiwanoha Urban Planning and Development Department Kashiwa-no-ha Omics Gate Secretary-General
Showcase: How Technologies Can Keep Your Healthy Mind
Healthtech Update:Jolly Good Inc.Bringing Medicine and Health Care Together with VR - The birth of a New Digital Health VR Platform -
The situation of hospitals became more critical due to the pandemic and the cooperation of professionals from different medical backgrounds is required more than ever.
Jolly Good, the leading company in the field of medical and welfare VR, is pleased to announce a completely new VR platform that integrates the knowledge and advanced technologies we have acquired through our VR business.
Sponsor Speech:Chugai PharmaceuticalBetter medical DX for all stakeholders: Utilozing RWD
In order to solve various issues in healthcare, It's important for us to realize "good medical care" for all people / patients, medical professionals, governments / local governments, and pharmaceutical companies by utilizing real world data (RWD). We would like to discuss the RWD utilization ecosystem with various stakeholders and build it together.
Healthtech Update:Aflac Life Insurance Japan
Keynote: How healthcare organizations should strengthen their cybersecurity during the pandemic
As the COVID-19 pandemic has forced the world to be more reliant on information technology, the number of cyberattacks is skyrocketing.
Unfortunately, the healthcare sector is one of the most targeted critical infrastructure sectors by ransomware attacks or cyber espionage. This keynote session aims to analyze the trend of cyberattacks and introduce cybersecurity measures to take by healthcare institutions.
Healthtech Update:Astellas PharmaBuilding the Rx+ Business
Astellas' Rx+ business will provide people with new VALUE by integrating innovative medical thinking with cutting-edge technology in different fields, building on the strengths developed from our prescription drug (Rx) business. Richard Cassidy, who became the head of Rx+ Businness Accelerator in October of this year, will give an introduction and share our thoughts on Rx+.
Showcase:Empowering Hospital Management
Healthtech Update:Sugi Pharmacy Co., Ltd.
Showcase: Women in Healthcare Through Femtech
Healthtech Update:Sumitomo Life Insurance CompanySumitomo Life’s action in the field of healthcare through open innovation
Planning Department, Business co-creation manager of SUMISEI INNOVATION FUND Sumitomo Life Insurance Company
Keynote: The Global Trend in Digital Therapeutics
Around the World Update:Ahead to the Center, Seeking the Essence of Healthcare
●●●●●●●●●●
●●●●●●●●●●
Keynote:Social implementation of “Technology that visualizes the senses” cultivated through the development of wheelchair racers.
WF01TR, a para-athletics wheelchair racer developed to maximize the athletes’ abilities, was based on the measured with figures of the seating simulator SS01 that quantifies and visualizes the athlete's senses. Currently, SS01 proposes “optimization of seat position” to general wheelchair users and aims to build a measurement analysis system using AI.
●●●●●●●●●●
●●●●●●●●●●
Showcase: Technologies to Conquer the Malignancy
Day 1 Wrap Up
Diversity of management team in the healthcare business
DeepDive:EY JapanA paradigm shift in digital health
The healthcare industry is going through a paradigm shift. There is an increased use of health data and a change toward patient-centeredness due to rapid digitization and 5G, AI, and sensor technologies. The COVID-19 pandemic is accelerating these trends. We will explain the latest trends and the strategies that companies should take with a case study.
DeepDive:Sugi Pharmacy Co., Ltd.Challenging to make a new contribution to the community by promoting DX
realizing wellness for local residents.
Today, we will introduce the challenges we are taking to contribute to the community through disease prevention using PHRs, disease awareness using apps for early detection and treatment, and in the therapeutic area, appropriate medication support using prescription data.
Present situation of the cyber security in hospitals
We achieved a surveyance concerning the cyber security situation in hospitals in collaboration with Japan Medical Association between July and August, 2021.We got the response from 586 hospitals out of 2479. We report the result of the analysis according to the bed-number and the kind of the founder of the hospitals
Fire-side chat:DX for pharmacies and medical care-feasibility through the thoughts and technology contained in the revision of the Pharmaceutical Machinery Law
DeepDive:Chugai PharmaceuticalPersonalized healthcare through medical data utilization
The conpept of personalized healthcare aims to maximize patient outcomes through providing optimal treatment options for individual patients by creating selective treatment approaches and developing, non-pharmaceutical solutions that utilize insights identified via advanced analyses of medical data. The challenges in promoting these actions will be discussed.
DeepDive:Life Science Innovation Network Japan（LINK-J）
Collaboration for the development of next-generation medical technology and healthcare services in the Kashiwanoha area-Formation of a life science base aimed at "curing" and "overcoming" cancer-
DeepDive:Astellas Pharma Rx+ Business Realized with Partners in Different Fields
Astellas is working on Rx+ business to provide people with new VALUE by integrating innovative medical technology with cutting-edge technology in different fields, based on the strengths cultivated in the prescription drug (Rx) business. In the session, we will introduce specific Rx+ programs, with a particular focus on collaboration with partners in different fields.
Doctorepreneur
Yuuri UedaMedPeer,Inc./Healthtech/SUM Director
After acquiring B.A. in law at Waseda university, Yuuri became M.D. at Okayama university. Her subspecialities are plastic surgery and homecare medicine, mainly takes care of decubitus in elders at home. As well as continuing her clinical practice, she started her career as a director for Health 2.0 Asia - Japan from April, 2017. She is heavily motivated in integrating medical practice and technologies, as she sees real needs for technologies in clinical situation.
Matthew HoltCo-Founder, Health2.0
Conference&Founder, The Health Care Blog
Matthew Holt, Co-Chairman, spent the 1990s learning from the best to be a health care futurist at Institute for the Future, and a survey researcher at Harris Interactive. In the early 2000s he spent time at a PHR start-up, but since he’s been the Founder of (and now occasional author on) The Health Care Blog, and co-founder of the Health 2.0 Conference–roles for which he was mostly self-taught!
Mihoko MatsubaraChief Cybersecurity Strategist, Security and Trust Office, NTT Corporation
Mihoko Matsubara is Chief Cybersecurity Strategist, NTT Corporation, Tokyo, being responsible for cybersecurity thought leadership. She served at the Japanese Ministry of Defense before her MA at the Johns Hopkins School of Advanced International Studies on Fulbright. Prior to joining NTT, she worked as VP and Public Sector Chief Security Officer for Asia-Pacific at Palo Alto Networks. She served on Japanese government’s cybersecurity R&D policy committee between 2014 and 2018.
Mihoko is a prolific writer and has spoken at various engagements internationally. She published a cybersecurity book in Japanese from the Shinchosha Publishing Co., Ltd. in 2019, which won an award by the Okawa Foundation for Information and Telecommunications in JFY 2020. She has given a talk at the RSA Conference 2018 and 2019 in San Francisco, the EU Cyber Forum 2019 in Brussels, and the NATO CCD COE International Conference on Cyber Conflict (CyCon) 2015 and 2019 in Tallinn, Estonia.
Eugene BorukhovichSerial intra & entrepreneur / Chairman & COO YourCoach Health / EIR at PHS Fund
Eugene is a serial intra and entrepreneur, executive, venture builder, speaker & board advisor with a focus in digital health. Eugene is a Chairman and Founding Board Member at YourCoach Health and founder of Initium Impact Ventures. Prior to YourCoach, Eugene served as a Global Head of Digital Health at Bayer. He has also co-founded and sold a doctor rating startup and a consulting company. Eugene enjoys running, writing, traveling and spending time with his family.
Takuma InamuraDirector, Healthcare Industries Division, Commerce and Service Industry Policy Group, METI (Ministry of Economy, Trade and Industry)
Takuma Inamura is Director of the Healthcare Industries Division at METI (Ministry of Economy Trade and Industry) of Japan.
He joined METI in 1998 and has mostly worked on policy making in areas such as energy, international trade and manufacturing industries. Before taking up his current position, he was the director in charge of a drastic revision of the Japanese legislation on the electricity supply business in order to enable the cost effective deployment of renewable energy and sustainable investment in the power grid system. He also has government-wide experience through his secondment to other Japanese ministries including the Ministry of Foreign Affairs (an Economy Counselor at the Permanent Delegation of Japan to the OECD) and Ministry of Finance (a Deputy Director in charge of budget for port and airport construction public works).
Yasuhiro OsugiVice-president, Toyota Regional Medical Center
Family physician
Associate Professor of Community based Medicine, Fujita health University
Vice President, Toyota Regional Medical Center
Graduate School of Management, Globis University
MD, MBA, PhD
Graduated from Fujita Health University
After working for nine years in the Department of General Internal Medicine at Iizuka Hospital and the Department of Family Medicine at Kaita Hospital, I started the Fujita Health University Family Medicine Program in 2015 with three other residents prior to the General Medicine Specialist System that started in 2018.
"Our mission is to improve the health of the community and the world by the standard of excellence in education.
Our program has expanded to the organization with 64 faculty and residents. The Toyota Regional Medical Center, the core of the hospitals, aims to become a community hospital that provides new hospital values.
Yo IwamiPresident & CEO (M.D, Ph.D), MedPeer, Inc.
Yujiro MaedaDirector, Tokyo Biodesign/ Co-Founder, Kozue Medical Cooporatin/Co-Founder, Premopartners Inc.
Yujiro runs a medical device startup incubator at the University of Tokyo, called Biodesign, in collaboration with Stanford University. Founded Premo Partner Inc., a medical technology incubator. Hosted Medtech Angels, Japan's first accelerator specializing in medical devices. Director of Aillis, a medical AI startup. Founder of Kozue-kai Medical Corporation, and owner of two dental clinics. Specially appointed professor at Tokyo University of Pharmacy and Life Sciences and lecturer at Waseda Business School. Dentist, PhD of Medicine.
Junichi TanakaChief Digital Officer (CDO) , Mie Prefecture
Born in Tokyo in 1976, he started a business at the age of 18 and incorporated it as an AI venture company in 1999. He ran a corporate group in the IT consulting business and advertising business for about 10 years. He also served as director of Euglena Co., Ltd. and CoCooking Co., Ltd.
Regarding regional revitalization, he worked on measures to address the declining birthrate, promote gender equality, and encourage people to move and settle in local areas in collaboration with various local governments.
In April 2021, he was appointed Chief Digital Officer (CDO) of Mie Prefecture. He has been promoting “Attakai-DX”（Attakai means heartwarming）, which helps individuals to achieve their visions, and improve sustainability and well-being. The prerequisite is to build a “tolerant society” founded on gender equality as well as diversity and inclusion.
He also serves as a regional revitalization evangelist of the Cabinet Office, regional digitalization advisor and regional power creation advisor of the Ministry of Internal Affairs and Communications, sharing-economy evangelist of the Cabinet Secretariat, member of the workshop to solve regional issues in the era of IoT/AI of the Ministry of Economy, Trade and Industry, and observer of the gender gap elimination strategy conference of Toyooka City, Hyogo Prefecture.
Ryosei WakabayashiPresident & CEO, neumo, Inc.
Ryosei Wakabayashi founded neumo in 2017 to devote his life to neuroscience. Focusing on the deep connection between sound and the brain, Ryosei develops services that employ music and auditory neuroscience and engages in research and development of technology for early detection, prevention, and improvement of hearing loss. Prior to establishing neumo, Ryosei founded and served as the executive vice president of beBit, a DX company. At beBit, Ryosei expanded the business to China and Taiwan and established the R & D department. Ryosei also launched the CVC and invested in neuroscience companies in the United States, Israel, and Ukraine.
Currently, Ryosei also serves as a special advisor to ATR (Advanced Telecommunications Research Institute International), which is one of the leading neuroscience research institutes in Japan. Ryosei previously served as a part-time lecturer at Kyoto University and the University of Tokyo.
Anri SugiharaCEO, RDS Co.,Ltd.
CEO and the design director of RDS Co., Ltd. and the founder and the head editor of HERO X. RDS Co., Ltd. has been engaged in research and development of various motor sports products for many years and has been an official partner of F1 team Scuderia AlphaTauri recently. In recent years, we have also developed competitive welfare equipment for parasports, and have been cooperating with para-athletes as partners for many years.
Awards : Good Design Gold 2013, A' Design Award Platinum and more.
DA’C World’s 2nd Best Designer in2021
Keita KondoToyota Regional Medical Center Home-care
Family physician, Community Doctor
Assistant Professor of Community based Medicine, Fujita Health University
Director of Home Visit Care Unit, Toyota Regional Medical Center
MD
He was born in Toyota City, Aichi Prefecture, and graduated from Aichi Medical University in 2014, completed medical intern at Toyota Memorial Hospital, and completed residency training at Fujita Medical University Family Medicine Program. During his training, he worked at Fujita Medical University Hospital, St. Luke's International Hospital, etc., and was involved in the launch of the Handa Central Hospital in 2019. He currently belongs to Japan's largest Family Medicine Program as an faculty and works as the director of the Home Visit Care Unit of the Toyota Regional Medical Center. He provides home visit care to more than 500 patients. His dream is to make Toyota City "the healthiest and happiest city in the world", and he is also active as a community doctor.
(About Community Doctor: https://kangotamago.com/2021/01/23/community-doctor/)
Daniel LewCommercial Service, U.S. EmbassyTokyo/Commercial Officer
Daniel Lew is a Commercial Officer at the U.S. Embassy in Tokyo where he supports American companies entering the Japanese market. He oversees the SelectUSA portfolio and covers the following sectors: healthcare, investment services, telecommunications, and digital services. Before his position at the U.S. Embassy in Tokyo, he served at the U.S. Embassy in Seoul where he managed the transportation, energy, travel & tourism, and education sectors. Lew graduated from the University of Chicago with an MBA degree and holds a BS degree from the University of Massachusetts at Amherst. He is fluent in English and Korean, and conversant in Japanese.
Michikazu KoshibaHead, Center on Global Health Architecture, General Manager, Social Impact Partnership Business Dept, Mitsubishi UFJ Research and Consulting Co., Ltd.
He started his career in International Development/Humanitarian Relief fields. Serving for disaster-affected community, the concept of sustainability/multi-stakeholder approach became the essential value for his career. Shaping his career as a consultant to dedicate his life to CSV(Creating Shared Values) business, especially on global health from the mid-2000s, he has worked with scores of corporations and startups, as well as with industry bodies, government, the media, NGOs, academia.
His favorite word of his role: “nexus between conventional politics and one of the future” Since 2016, he established a P3 forum “Access to Health” where the members are focusing on a contribution to global health including Infectious Diseases, Nutrition, NCDs, MCH and health service delivery to transform health system. Digital health is a key component. He plays a role as a facilitator/coordinator for multi-stakeholders in a global arena, working as the HEAD, Center on Global Health Architecture, MITSUBISHI UFJ Research and Consulting.
Yu HasegawaDeputy Head - Healthcare Business, Center on Global Health Architecture / Deputy General Manager, Social Impact Partnership Business Department, Mitsubishi UFJ Research and Consulting Co., Ltd.
Yu Hasegawa joined Mitsubishi UFJ Research and Consulting (MURC) as Deputy Head - Healthcare Business, Center on Global Health Architecture in August 2019. He is in charge of new business development and consulting in the field of global health. He is leading operation of a new initiative, WELCO Lab for Global Health, which was established in 2020 to encourage Japanese companies to contribute to global health issues. Prior to MURC, he worked for Astellas Pharma Inc. for 10 years in several fields such as clinical development, global health, sustainability, strategic planning and portfolio management. MSc from Graduate School of Science, Kyoto University and MBA from Kenichi Ohmae Guraduate School of Business.
Ritsuko YamagataMitsubishi UFJ Research and Consulting Co., Ltd.
Deputy Head - Health Policy for UHC, Center on Global Health Architecture / Global Health Senior Expert, Social Impact Partnership Business Department
Ritsuko Yamagata joined Mitsubishi UFJ Research and Consulting (MURC) as Deputy Head - Health Policy for UHC, Center on Global Health Architecture in September 2019. She is in charge of conducting researches in the field of global health, focusing on stregthening of health systems and UHC. She has been involved in the projects for Ukraine, Bhutan, Latin American region, Cote d'Ivoire, etc. Prior to MURC, she worked for Japan International Cooperation Agency (JICA) for 20 years, managing various projects to improve health systems mainly in Africa and South Asia. MPH from Johns Hopkins Bloomberg School of Public Health.
Tomoya NakanishiGraduate School of Arts and Sciences, The University of Tokyo. （JSPS Research Fellow)
NTT Data Institute of Management Consulting, Inc.
Mr. Nakanishi is a Research Fellow of the Japan Society for the Promotion of Science, working on research at the University of Tokyo Graduate School. He specializes in neuroscience, and his brain research, especially with para-athletes, has revealed the hyper adaptation of their bodies and brains. In other words, there are abilities, thoughts, and sensitivities that individuals with disabilities could only demonstrate; however, these possibilities have not yet been implemented in the social system in Japan. His mission is to work on this issue and create the next symbiotic society. He has also been working on the social implementation of neurotechnology at NTT Data Institute of management Consulting, Inc. since 2021.
Yuma KajiwaraNTT DATA INSTITUTE OF MANAGEMENT CONSULTING, Inc.
Digital Strategy Business Division
Business Transformation Unit
Senior Consultant (Physical Therapist)
Completed the Graduate School of Sports Science at Waseda University. After working as a physiotherapist at general hospitals and university-affiliated hospitals, a university-launched venture that developed an exoskeleton-type assistive suit using artificial muscles as actuators, and a health-tech company that operates healthcare and fitness apps, I am now in my current position. I am engaged in strategic consulting that utilizes the latest technology in healthcare, sports, education, urban development, and tourism, utilizing insights based on the voices and knowledge of the field accumulated in the healthcare industry. Major media in which I have appeared include World Business Satellite and DIME (Shogakukan). I am a member of the board of directors of the Japanese Society of Preventive Physical Therapy, and the acting director of the Sports-Tech & Business Lab.
Kei-ichi ShibaharaAmvis holdings, Inc. CEO
After graduating from Nagoya University School of Medicine, I received PhD from Kyoto University Graduate School of medicine. After that, I devoted myself to research in molecular biology for 20 years. In 2010, I decided that it would be nice to have a second chapter in my life, so I quit my research job and became an entrepreneur. I moved to Iwate Prefecture to test my business hypothesis on the theme of "revitalizing community healthcare in depopulated areas. After various social work activities and efforts to rebuild a medical corporation, I established Amvis, Inc. in 2013. I tested my business hypothesis of "a medical facility that outsources the function of doctors from hospitals" as a hospice business. In 2019, the company was listed on the JASDAQ. I aim that company will lasts 100 years by taking on the challenge of solving medical issues through innovation in mechanisms.
Norito KawakamiProfessor, Department of Mental Health, Graduate School of Medicine, The University of Tokyo
Dr Kawakami graduated the Graduated School of Medicine, Gifu University in 1981 (receiving MD), and the Graduated Graduate School of Medicine, The University of Tokyo in 1985 (majoring Social Medicine) (receiving PhD). After serving as Associate Professor of Department of Public Health, Gifu University School of Medicine (1992-2000) and Professor of Department of Hygiene & Preventive Medicine, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Science (2000-2006), he became Professor of Mental Health, School of Public Health, the University of Tokyo since 2006. He has worked in the public and occupational mental health fields over 40 years, particularly on nation-wide community-based epidemiologic studies of mental disorders and digital mental health interventions in the workplace. He is also past Presidents of Japan Society of Occupational Health and Japan Society of Occupational Health. He received the Medal with Purple Ribbon from The Emperor of Japan in 2020.
Chikara MatsuzakiCEO, Kenko Medical Service Co., Ltd
RIZAP GROUP, Inc.
・Graduated from State University of New York
・Launch and operation of medical fitness at the hospital
・Joined RIZAP Co., Ltd. Overseas Division
・Education/Development Department Healthcare: Promote the development of medical trainers
・Corporate Sales Department Healthcare: Launch services for corporations and local governments
・Kenko Medical Service Co., Ltd. CEO
Naoto FukutaniCEO, BackTech Inc.
I was received his doctorate degree (PhD) from the Kyoto University Graduate School of Medicine. From that time forward, he founded Backtech,Inc. and became the representative director. While serving as a researcher at Kyoto University Graduate School of Medicine and Industrial Medical University, he has written 33 international research treatises and is working on the development and operation of evidence-based healthcare services. Currently, Fukutani and the team are developing a product named "Pocket Therapist" service to help and support, and to improve the productivity of workers in big corporations by working on high-stress countermeasures. It has a large number of introduction records mainly by major companies and health insurance associations."Pocket Therapist" won the highest award at Health 2.0 Asia-Japan 2018.
Hiroki FujimotoSenior Executive Officer, General manager, Next Business Planning Department, Business co-creation manager of SUMISEI INNOVATION FUNDSumitomo Life Insurance Company
Joined Sumitomo Life Insurance Company after graduating from the University of Tokyo, Faculty of Economics. After being seconded to the Ministry of International Trade and Industry (currently the Ministry of Economy, Trade and Industry), became the Manager of the Secretarial Section in 2005 and the Manager of the Corporate Governance Section in 2007. Handled launching the new brand strategy in 2011, became the General Manager of the Brand Communication Department in 2013. In 2017, won the Minister for Internal Affairs and Communications Award / ACC Grand Prix at "ACC TOKYO CREATIVITY AWARDS", which is one of the largest advertising awards in Japan ("A category" of "Film Section"). Leading open innovation in Next Business Planning Department from April 2019, and has been an Executive Officer, General Manager of the Next Business Planning Department，Business co-creation manager of SUMISEI INNOVATION FUND since April 2021.
Kumiko Takahashi Deputy Director, Healthcare Industries Division,
Ministry of Economy, Trade and Industry
In the healthcare industry policy, I mainly promote startup support and international expansion.
I have worked on the inviting Osaka-Kansai Expo 2025, trade policy and business development in an AI startup.
Go FujitaCEO, MTG Ventures,Inc.
Graduated from Faculty of Economics, Meiji University. Then, joined Japan Associated Finance Co., Ltd.(Currently named, JAFCO Group Co., Ltd.) in 1997. Transferred to the Investment Department, Chubu Branch of JAFCO in 2005 and promoted to the President of Chubu Branch in 2015. Participated in the investment support of various investment companies from start-up stage to later stage, and also acted as a Borad member of each invested company. Invested in the area of Auto-driving, AI, Childcare IoT, etc., and inversted to the splited companies. Based on the rich experience of working with over 6,000 management people, currently challenging for the investment area of VITAL LIFE.
Shunichiro ItoCEO, LEBER, Inc.
<Biography>
・ 2004 Graduated from the University of Tsukuba School of Medicine
・ 2004-14 Cardiovascular surgeon in a variety of medical institutions
・ 2014 Started a home-visit medical care service, a nursing service and a nursing home business
・ 2017 Founded LEBER,Inc. (formerly AGREE), a telemedicine App business
Since April 9, 2020, we have provided free healthcare consultation services in collaboration with the Ibaraki Prefecture. With the aim of providing a service needed in the time COVID-19, we have added a body temperature, health condition, and an attendance-checking function. Having grown rapidly, our App is already adopted by 1000 educational institutions nationwide.
Hiroshi FukatsuProfessor and Director of Medical Informatics, Aichi-Medical University. Representative Director of Medical ISAC Japan
Graduated from Nagoya University School of Medicine in 1985. Promoted as an Assisstant Professor of Radiology, Nagoya University Hospital in 2002. Moved to Aichi-Meical University as a Professor and Director of Medical Informatics in 2009. Launched Medical IT Security Forum in 2014 and renamed as Medical ISAC Japan in 2020. Agreed conrehensive collaboration with Health ISAC USA in 2019. Continuously promoing enlightment activities for cyber security in medical sector.
Yasuhiro WadaCEO, Maris creative design Inc.
After completing his graduate studies at Kyushu Institute of Technology, he joined Hitachi, Ltd. In 2007, he joined Sony Corporation, where he was involved in the development of the single-lens reflex α and AIBO. In 2018, he established Maris creative design Inc. and developed "seeker", a walking assist device for the visually impaired. In 2018, he founded Maris creative design Inc. and developed "seeker," a walking assist device for the visually impaired. He has conducted demonstration tests in Kitakyushu City, Fukuoka Prefecture, and has won numerous contests, including the Excellence Award at the Asahi Kasei Group Acceleration Program and the Kyocera Award at Sony Startup Switch 2021.
Translated with www.DeepL.com/Translator (free version)
Go NagasakaCEO, A10 Lab Inc.
Born in Shizuoka, Japan in 1982, I graduated from Tokyo University of Technology with a degree in Media Studies and joined Sony Corporation in 2006. I founded A10 Lab Inc. as an independent company from Sony's Seed Acceleration Program, a new business creation program.。
Shigeru HandaDirector, Asia Africa Investment and Consulting Pte Ltd
Shigeru Handa is a seasoned professional with over 20 years combined with early-stage investments and business development consulting experience in the private sector as well as international development. Shigeru is a Director of Asia Africa Investment and Consulting Pte Ltd and manages Africa Healthcare Fund (Growth Capital) which invested 30 companies in Africa. He is in charge of sourcing and investing in innovative start-ups in growth as well as advising start-ups / corporations on business expansion strategy in Africa and the Middle East. He also supports an enhancement of startup ecosystem through provision of acceleration programm with the support from JICA.
He has worked at Japan Bank for International Cooperation, Boston consulting group (BCG: Japan), Natural Lawson (franchise consumer business) and United Nations Development Program.
Keiichi MurayamaCommentator, Nikkei Inc.
Keiichi Murayama formerly served as the U.S. Silicon Valley bureau chief of Nikkei Inc., and was a senior staff writer and an editorial writer of Nikkei. After earning his undergraduate degree at Tohoku University in 1992, he joined the Business News Department of Nikkei in Tokyo as a staff writer. He covered technology, medical, automotive, and financial news. After he joined the Program on US-Japan Relations of Harvard University, he went on to oversee the U.S. Silicon Valley Bureau for a few years. He's authored "Rise and Fall of the IT Empire - Steve Jobs Revolution” and “STARTUP - Real of Entrepreneurs”.
Yuji YamamotoFounder and CEO, MinaCare Co., Ltd.
Founder and CEO, MinaCare Co., Ltd.
Yuji Yamamoto, M.D., M.B.A.
Yuji Yamamoto is a founder and chief executive officer at MinaCare, Co., Ltd. which helps health and productivity management through health data analysis and community engagement promotion. He concurrently serves as a member of committees of the Ministry of Economics, Trade and Industry, dedicating health care system reform. He is also active in education through his lecture series for healthcare, business, and government leaders.
Before starting these careers, Yuji spent six years as a practitioner in several leading hospitals including University of Tokyo Hospital and Tokyo Metropolitan hospitals.
Yuji received his M.D. degree from University of Tokyo and his medical license. He is a board certified member of the Japanese Society of Internal Medicine and holds an M.B.A. from Harvard Business School.
After graduating from the Faculty of Business Administration at Kobe University, he worked for a major eyeglass retail chain company, where he was involved in CSR projects such as disaster countermeasures and new business development related to health. From 2019, he will participate in the "Research and Development of Remote Neonatal Resuscitation Training Simulator for Learning from Anywhere" adopted by the Ministry of Internal Affairs and Communications (MIC) as part of the Strategic Information and Communications R&D Promotion Project (SCOPE), a social deployment-oriented research and development program. We are currently promoting the development of a realistic training stethoscope hardware prototype and smartphone/tablet application by utilizing our know-how in IoT and medical device development.
Takahiro Mizoguchi, Ph.D.CEO, Motion Lib, Inc.
Dr. Mizoguchi graduated from the Graduate School of Science and Technology, Keio University in September 2014 and he engaged in the practical development of haptics technology at the Kanagawa Institute of Industrial Science and Technology after graduation. In April 2016, he established the company (current Motion lib, Inc.) and he was appointed CEO.
Since his university days, he has been involved in "RealHaptics," a control technology originating from Keio University, and continues to develop innovative force-haptics solutions, including remote control with tactile sensation. At Motionlib, Inc., he is promoting social diffusion of the technology by selling AbcCore, a force-feedback controller IC chip that incorporates RealHaptics algorithms, and by providing implementation support to companies.
Mark IchikawaHead of Fund Development Office, READYFOR Corporation / Visiting Associate Professor, Hiroshima University School of Medicine
Healthcare evangelist／Journalist／Educator
After graduating from the University of Tokyo's School of Medicine in 2000 , he joined NHK（Japan Broadcasting Coporation）. After being a visiting scholar at Stanford University in 2016, He works as a journalist and educator, primarily in the field of health communication. In 2019, he received the Yahoo! News Individual Author Award for his continuous work in the field of health care journalism.
Hisahiko SatoPrecision inc/CEO doctor
Born in Gunma Prefecture. Graduated from the University of Tokyo, Graduate School of Science, Chiba University School of Medicine, and the University of Colorado, Colorado Springs MBA. After working at Yokosuka U.S. Naval Hospital and Elsevier Japan, a medical publishing company, he founded Precision in 2016. He is also a researcher of artificial intelligence (AI).
Ayumu ShinodaKanagawa Prefectural Government
ME-BYO Industry Group Inochi and Future Strategy Headquarters Office, Policy Bureau
After gaining comprehensive experience in the Office of General Affairs of the Public Health and Welfare Bureau, transferred to the municipal government (Isehara City), in charge of the promotion of commerce, industry and tourism.
Obtained several government subsidies, worked with local people and private companies on various projects, and implemented a number of projects to promote the region, mainly by utilizing cultural assets and other resources.
After that, joined current position to work with a wide range of companies and academia to solve local health issues and build a new healthcare business.
Current main duties as a government official and responsible for overall coordination and planning, include supporting demonstration projects in the field of ME-BYO and healthcare, industrial promotion, university research support, and industry-academia-government collaboration.
Sophia PlessierTitan Consulting/ Business Development Manager
Sophia is the Business Development Manager at Titan Consulting, an award winning executive search firm, where she is responsible for developing and nurturing new client relationships throughout Japan. Since 2015, she has worked in executive recruitment in San Francisco in pharmaceutical, biotechnology, medical device and technology industries where she specialized on diversity hiring before moving to Japan in 2020.
Sophia founded the podcast Women in Healthcare—Japan along with a networking group of the same name where women can come together to empower other women in the industry.
Born in Paris, France, but raised in California, Sophia can speak French, English and some Spanish. She attended the University of California, Davis where she graduated with two Bachelor of Arts in International Relations and French Literature.
Since she has lived in France, United States, Italy, Spain and now Japan, Sophia has a deep passion for understanding and discovering new cultures.
Sho Hashimoto, M.D., Ph.D.Executive Board Member, Japan Medical Association
Otolaryngologist, Honorary President of National Sendai Medical Center in January 2020, after serving President. Board Member of National Hospital Organization from 2017 to 2019. After graduating from Tohoku University School of Medicine in March 1978, he worked as Assistant, Lecturer, Associate Professor for the Department of Otolaryngology of Tohoku University and Visiting Professor of Tohoku University Graduate School of Medicine in January 2020. He was engaged in research at Massachusetts Eye and Ear Infirmary and Harvard University for two years since 1984 and served as Visiting Lecturer at University of Copenhagen in Denmark in 1988. He has served as Vice President of Miyagi Medical Association since 2018. He was a delegate of Japan Medical Association, JMA, House of Delegates in 2008 and served as Chair of JMA’s Finance Committee from 2014 to 2020, then he was elected to Executive Board Member of JMA in June 2020.
Tadayuki MizutaniDirector Division for the Coordination of Health Care and Long-term Care
Health Insurance Bureau, MHLW
March 1997: Graduated from the University of Tokyo (B.A. in Law)
April 1997: Joined Ministry of Health and Welfare (MHW)
April 1997- July 2014: Health Policy Bureau, Minister’s Secretariat, Health and Welfare Bureau for the Elderly, Health Insurance Bureau, Social Welfare Bureau, Department of Health and Welfare for Persons with Disabilities, Office for Social Security of MHW/MHLW, and First Secretary at the Embassy of Japan in Washington, DC
July 2014-: Director, Office for Dementia, MHLW
June 2016-: Director for General Coordination, Minister’s Secretariat, MHLW
August 2017-: Secretary to the Minister of Health, Labour and Welfare
October 2018-: Director for General Coordination, Minister’s Secretariat, MHLW
September 2019-: Counsellor for General Coordination, Minister’s Secretariat, MHLW
September 2020-: Secretary to the Chief Cabinet Secretary
October 2021-: Director, Division for the Coordination of Health Care and Long-term Care, Health Insurance Bureau, MHLW
Ryo KubotaRepresentative Executive Officer, Chairman, President and Chief Executive Officer, Kubota Pharmaceutical Holdings Co., Ltd.
Dr. Kubota is an ophthalmologist by training and spent his early career performing ocular research at Keio University, where he earned his MD and PhD in medicine. He there discovered the glaucoma gene, myocilin, and earned him the Suda Award for his contribution to the field of neurodegenerative retinal diseases. Dr. Kubota continued his research at the University of Washington and later licensed his findings as the core technology on which he founded Kubota Vision in 2002 to develop novel therapeutics for patients with blinding eye diseases. In 2016, Kubota Vision became a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., listed on the Tokyo Stock Exchange Mothers Board.
Dr. Kubota has been a director of the Japan-America Society of the State of Washington and a board member of the National Bureau of Asian Research and Seattle Symphony. In 2019, he was appointed as NASA's Human Research Program Investigator.
Dr. Snehal PatelChief Executive Officer & Co-founder, MyDoc
Dr. Patel moved to Singapore from the US in 2008 to found and lead the healthcare team at the Chandler Corporation, a multi-billion dollar investment fund. Prior to practising law at Cravath, Swaine & Moore, LLP in New York, Dr Patel received an MD and a JD from Columbia University and served as a Clinical Fellow at the Harvard Medical School. He currently leads MyDoc to drive digital health transformation across Asia for safer, more effective care.
Katsunori SugiuraPresident and Representative Director of Sugi Holdings Co., Ltd.
Graduated from Pharmaceutical School of Gifu Pharmaceutical University in 2001.
Joined Johnson & Johnson Co., Ltd. in 2003
2006 Joined Sugi Pharmacy Co., Ltd.
In 2017 he took office as President and Representative Director of Sugi Pharmacy Co., Ltd.
In 2021 he took office as President and Representative Director of Sugi Holdings Co., Ltd.
We will deepen the area of "maintenance of health", "premature illness" and "prevention", so that everyone in the community can live a healthy and pleasant social life both physically and mentally, by experts on improving "eating habits" and "moderate exercise" Promoting realization of "wellness" of customers by supporting maintenance and promotion of aggressive health such as advice
"Based on the philosophy of" wishing for the happiness of all people and increasing the smile ", we aim at the existence which can be relied upon from the community at ease, conveniently and casually.
Masuomi TomitaCenter for Diabetic center, Shimo-kitazawa Hospital
2016 May
Director of Diabetes Center, Shimokitazawa-Hospital, Tokyo, Japan
2013
Internal medicine, Saiseikai Central-Hospital, Tokyo, Japnan
Taro YokoyamaClinic director, Yokoyamaiin home ・palliative care clinic Koutokukai Medical corporation association
I’m a doctor, working in oncological examinations such as chemotherapy, palliative care units, and home care services.
From now on, I think it’s more important in medical care to think about how we live with diseases and disabilities.
When you are diagnosed, information and carers are essential for your better decision-making.
I am working on changing long and difficult doctor's explanations into short and easy-to-understand videos.
This video is made with a communication designer who is making TV commercials.
By doing so, the patient's understanding is deepened and communication is activated.
In addition, we are creating a community so that patients and their families can have a counselor outside the medical staff when they are in trouble.
Tomohiro TadaCEO, AI Medical Service Inc. /
The director, Tada Tomohiro The Institute of Gastroenterology & Proctology
Dr. Tada is the CEO of AI Medical Service Inc., the director of Tada Tomohiro The Institute of Gastroenterology & Proctology, and a part-time lecturer at the Department of Surgical Oncology, Graduate School of Medicine at the University of Tokyo.
Dr.Tada has received his Ph.D. in 2005 and M.D. in 1996 of surgery from University of Tokyo School of Medicine. He trained colorectal surgery at University of Tokyo Hospital
Hiroshi OtsukaCEO, PST Inc.
I joined a supercomputer manufacturer, Nihon Cray Corporation, in 1995, after graduating from university.
Nippon Cray merged with SGI Inc., and I served as General Manager of the Graphics Business Department, Executive Officer, and General Manager of the Strategic Business Development Division at SGI.
In 2008, I founded Segway Japan Inc. through an MBO and became its President. I am now the Chairman of the Board and have conceived and developed the robotics business as a new business.
I believe that voice pathology analysis technology will be important in society coexisting with robots realized soon. Therefore, I am trying to expand the business of PST Inc., which has speech pathology analysis technology as its core technology, to include overseas expansion.
In addition to the above, I am active in a wide range of fields, including part-time lecturer at universities and corporate advisor.
Hiroaki KatouMinistry of Health,Labour and Welfare
Health Service Bureau,Vaccination Policy Planning Office,Deputy director
Joined the Ministry of Health, Labour and Welfare (MHLW) in 2009 after graduating from university.
2018-present MHLW Deputy director, Vaccination Policy Planning Office
<Before COVID-19>
- Dealt with rubella outbreak from 2018-2019
- Project manager of national rubella vaccination project in Japan
<During COVID-19>
- Project manager of national COVID-19 vaccination project in Japan
- Tracking COVID-19 vaccine distribution and analyzing COVID-19 vaccination coverage
- In charge of a team of over 250 engineers from NEC, a major IT corporation in Japan, and developed a new vaccine supply management system called V-SYS
Takuji FurukawaPresident & CEO (Ph.D), B dot Medical Inc.
Dr. Furukawa joined the NIRS (National Institute of Radiological Sciences) as a student then has been involved not only in the design and development of particle therapy systems but also in numerous treatment operations. His specialization is scanning technology which makes it possible to irradiate the tumor accurately, and he succeeded in developing the world's first clinical application of "respiratory gated scanning irradiation," which had been considered impossible (Minister of Education Award for Science and Technology in 2012). At the NIRS, he and his team have provided technical support to facilities and manufacturers of particle therapy systems, but his desire to better meet the needs of the clinical side led him to found B dot Medical Inc. in 2017, which develops an ultra-compact proton therapy systems.
Memori FukudaDepartment of Health Informatics, Graduate School of Medicine & School of Public Health, Kyoto University
Medical Administration Division, Aillis, Inc.,
After graduating from Tokyo Women's Medical University School of Medicine, she worked in the Department of Cardiology at the National Hospital Organization Tokyo Medical Center before joining the Department of Cardiology at Keio University, where she is currently an Assistant Professor. While continuing her clinical practice, she joined Aillis, Inc., a start-up company developing AI medical devices, in 2019 and is engaged in clinical development. She also works as an occupational physician from the perspective of preventive medicine, and is conducting research in the field of public health at Kyoto University Graduate School from 2020. She is also a member of the Public Relations Committee of the Japanese Circulation Society and a science writer for Yahoo.
Yutaka NakakoPresident & CEO (M.D, Ph.D), KAKEHASHI, Inc.
Worked as a medical representative at Takeda Pharmaceutical Company Limited. Seeing patients waiting for a long time at hospitals and pharmacies, realized better user experience can be provided through better IT medical infrastrucutres. Founded KAKEHASHI, Inc. in 2016.
KAKEHASHI provides SaaS for pharmacies, which innovates patient experience at pharmacies and reduces paper work of pharmacists.
Huang HaoCEO, Mirror Fit Co.,Ltd.
After graduating from Waseda University, joined Mitsubishi Corporation, a general trading company, and engaged in trading of digital home appliances, automobile parts, and steel products for industrial plant facilities.
He left the company after being stationed overseas in Mexico.
After that, while managing the international logistics business in the family business, he established RILISIST Co., Ltd., and currently manages about 15 personal gyms and all-you-can-eat salons nationwide.
In 2020, he established Mirror Fit Co., Ltd. and developed a new type of online fitness business utilizing the smart mirror device developed in-house. We aim to create a platform that not only eliminates the user's pain such as "I want to go to the gym but I don't have time" and "I can't continue every day", but also realizes a new way of working for trainers.
Takuya Naganawa
Kazuhito GoshimaRepresentative Director and Representative Partner, iSGS Investment Works Inc.
After working at a bank, mainly in charge of corporate financing, he joined Softbank Finance Corporation, where he was engaged in the discovery of investee companies, investment execution, management support, fund management, and the launch of business subsidiaries.
In 2006, he joined DeNA Co. In 2006, he joined DeNA, Inc., where he was responsible for investment and M&A and led many investments and acquisitions, including the acquisition of Yokohama DeNA BayStars, Inc. At the same time, he participated in the post-acquisition PMI of domestic and overseas companies as a management member.
In 2014, he joined Coropla Inc. Ltd. in 2014, where he continues to be involved in venture investments and M&A. His major investment experience includes Lancers, Inc.
In June 2016, he established iSGS Investment Works Inc. and became Representative Director and Representative Partner.
Akira SuzukiGeneral Manager, Business Div., HIROTSU BIO SCIENCE INC.
・8 years of experience in consulting sales at Adecco.
・Joined Rare Job in 2014 and worked as a Corporate Business Manager and Business Planning Manager. From 2019, Promoted the company's partnership strategy, including expansion to Bangkok, trade alliances and collaborations between industry and universities.
・Joined HIROTSU BIO SCIENCE as Business Manager, responsible for the company's growth strategy.
Darren GoffBritish Embassy Tokyo, Director of Trade and Investment, Deputy Trade Commissioner, North East Asia
Darren Goff is the Director of Trade and Investment for Japan (based at the British Embassy in Tokyo) and the Deputy Trade Commissioner responsible for North East Asia. Darren leads a team across the Japan, South Korea and Taiwan markets focussed on strengthening commercial partnerships with the UK.
Darren has spent most of his career working for the Department for International Trade (DIT) and the Department for Business, Energy and Industrial Strategy (BEIS). Before moving to Japan in 2016 to head up the investment team, he led the Strategic Relationship Management Programme (SRM) in London which focussed on supporting the largest 80 foreign companies with UK operations and the largest 20 UK companies exporting from the UK. He is a qualified management accountant and previously headed up the Finance and Performance team focussed on investment in DIT.
Satoshi FukushimaDirector, GLOBIS CAPITAL PARTNERS & Co.
Satoshi Fukushima joined Globis Capital Partners (GCP) in April 2014. He leads health-tech investments and act as an outside board member of various companies such as Medley (9984), KAKEHASHI, AI Medical Service, justInCase, etc. Prior to GCP, he worked at Deutsche Securities Inc. and engaged in various M&A advisory and financing transactions. He received BA in Economics from the University of Tokyo.
Miki OotaDirector of Pharmaceutical Director of Pharmaceutical Affairs
General Affairs Division
Pharmaceutical Safety and Environmental Health Bureau
Ministry of Health, Labour and Welfare
Takuya SaekiManaging Director, DynaTrek, Inc.
Graduated from Faculty of Policy Management, Keio University in 2003.
In his first career at PRAP Japan, largest independent PR agency in Japan, Takuya engaged in PR strategy planning for global IT vendors and consumer products manufacturers.
Joined DynaTrek, Inc. in 2009, currently in charge of corporate planning and marketing of DynaTrek.
Shinya SaekiProduct Manager, DynaTrek, Inc.
Graduated from the Faculty of Policy Management, Keio University in 2006. Joined DYNATREK, Inc. in the same year. Currently in charge of planning, development and project management of DYNATREK, a data integration and analysis tool, as Director.
Also involved in obtaining patents in Japan, the U.S., China, and Singapore for the Data Connect algorithm of the tool, and advocates a data utilization tool that realizes "analysis that leads to action".
With strength in supporting business reforms using Data Connect technology, leads numerous data integration and utilization projects for financial institutions, government agencies, telecommunications companies, and electric power companies, etc. Currently promoting the use of this product, which has a market share of over 40% of Japan's regional banks, in the medical and life science fields.
Yusuke FukujinRepresentative Director & President, Alfresa Corporation
In March 1999, graduated from Keio University Faculty of Law. In April 2000, joined Alfresa Corporation. Became the representative director of Specialty Medical Distribution Corporation, a subsidiary specializing in the distribution of specialty drugs, in June 2016, and engaged in the establishment of a unified distribution scheme for rare disease medicine. In June 2020, became the representative director of Alfresa Corporation.
Yasunori IshizukaManager, Business Development Office, Corporate Planning Department, Corporate Headquarters, Alfresa Corporation
Born August 5, 1980. Mr. Ishizuka has experience in the corporate strategy, sales planning, and logistics management in the Alfresa Group, and is mainly engaged in improvement of the last mile logistics of ethical pharmaceuticals to medical institutions. In 2018, he engaged in joint development of "Saios", the drug delivery support tool for sales assistants with Navitime Japan Co., Ltd., based on "Business Navitime Fleet Management Solution." Since the establishment of "Pharmaceutical Distribution Study Group," in 2019 with Yamato Transport Co., Ltd., to investigate future medical care provision systems and social issues such as labor shortages, Mr. Ishizuka is responsible for construction of a joint delivery scheme for healthcare products with Yamato Transport Co., Ltd.
Tomoya UtsudeDirector, First Senior Vice President, Aflac Life Insurance Japan Ltd.
Born in Kyoto Prefecture. Graduated from Tokyo University Faculty of Medicine in 1986. After stints in the First Surgical Department at Tokyo University, and Department of Pathology at Cancer Institute, etc. he joined Aflac in 1994 and was involved in insurance underwriting, payment, product development, etc. primarily in cancer insurance.
Presently, he is working on collaboration/cooperation with various internal and external players toward building a "Cancer Ecosystem" aimed at resolving social issues surrounding cancer patients and their families.
Shohei AraiHANOWA inc. CEO
After working for Intelligence Inc. and a web production company, became independent as a web marketing consultant. Started recruiting support, after helping dental clinics attract patients. Delayed work style reform in the dental industry was a major problem. HANOWA was established to help women in the dental industry realize a work style that fits their life events.
Takafumi Kawanoyocto Co.,Ltd
Over 20 years as an engineer and over 10 years of yoga experience.
I've had a background as a yoga studio manager and yoga instructor.
Established Yocto Co., Ltd. in 2017. With a mission of "connecting and spinning a mind and body of people and society around the world,".
We would like to face many challenges at yoga and wellness industry while developing and providing services to support advanced lessons and training by utilizing IoT mats and data in order to realize DX.
Tetsuro SanoEY Japan Health Sciences and Wellness Consulting Leader, Life Sciences Sector Consulting Leader, EY Strategy and Consulting Co., Ltd.
Tetsuro Sano is EY Japan Health Sciences and Wellness Consulting Leader, Life Sciences Sector Consulting Leader.
Having joined the firm in 2016, he provides management consulting services for life science companies in Japan and overseas, including the pharmaceutical and medical device sectors.
He advises clients on all aspects of the value chain, from medical and commercial to R&D and supply chains. He actively promotes business transformation in the life sciences industry, lecturing and holding seminars for industry companies and groups.
He earned a master’s degree in finance from the London Business School and a master’s degree in management from the University of Oxford, both in the UK. He majored in accounting at Kentucky State University, USA.
Hironao YazakiEY Japan Health Sciences and Wellness Leader, Life Sciences Sector Leader, Ernst & Young ShinNihon LLC
Hironao Yazaki is the Health Sciences and Wellness Leader and the Life Science Sector Leader at EY Japan. He provides audit services across the sector, including the pharmaceutical and medical equipment industry, bio ventures and hospitals.
Drawing on his extensive experience in life sciences and auditing, Hironao has served as local government commissioner, university lecturer, and as a committee member of the Japan Institute of Chartered Public Accountants (JICPA). He has also authored a guide to the impact of IFRS on the pharmaceutical industry.
Prior to joining EY, he worked in the manufacturing industry.
He is a Japan Certified Public Accountant and a graduate of the Faculty of Economics at Tokyo’s Keio University.
Taku IwamiKyoto University Health Service
1996 M.D. Faculty of Medicine, Gunma University, Maebashi, Japan
2005 Ph.D. Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine
2006 M.P.H Master of Clinical Research, Kyoto University School of Public Health, Kyoto, Japan.
Professor of Department of Preventive Services, Kyoto University School of Public Health.
President of the PHR Promotion Council.
Specialities: Clinical epidemiology, cardiology, resuscitation science, and health science.
I am working to improve the quality of PHR services and implement and develope them through industry-government-academia-private partnerships.
My future dream is to be a log-builder and a fisherman.
Hajime SatoGlobal Head of Partnerships -Japan, Galen Growth / Founder & CEO, MEPLA Japan Co., Ltd.
Hajime is Founder & CEO of MEPLA Japan, health-tech accelerator and the advisory firm in medical industry. Hajime founded MEPLA Japan and has worked with Japanese hospitals and healthcare related companies for their overseas business expansion in SEA market. Hajime has also produced several businesses in medical / healthcare industry as entrepreneur. With his background as the entrepreneur and investor, Hajime is connecting and supporting the health-tech startups for the healthcare innovation.
Hajime received BA in Economics from Hitotsubashi University.
Chisako YokomatsuM.D
She is a pediatrician at the intensive care and emergency department. She started to participated in operating " Health 2.0 “ from 2017.
Levi ShapiroManaging Partner, LSV Capital; Founder, mHealth Israel
Kanae KanekoPhilduct Inc.
Kanae graduated from the Department of Oral Health, School of Dentistry, Tokyo Medical and Dental University in 2017. At the same time, she obtained a national license as a dental technician.
In 2019, she completed the course in Health Policy, Graduate School of Medical and Dental Sciences, at the same university. Her research interests are community dental health care and digital dentistry. While in graduate school, she conceived of an orthodontic business with a new business model as she sought social implementation to change the dental industry. She founded Philduct Inc. in 2018 while still in school, and started full-scale business after graduation, releasing it as “DPEARL” in 2020.
She has been selected for the APTwomen by the Tokyo Metropolitan Government, and won an award at the ICC Catapult KYOTO 2020.
Saho MurakamiPharmaceuticals and Medical Devices Agency Office of New Drug Ⅲ Medical Reviewer
Dr. Murakami graduated from the Faculty of Economics, Kyoto University, and the Okayama University Medical School. After her initial training at Kurashiki Central Hospital, she worked as an ophthalmologist at Keio University Hospital and Kitasato Institute Hospital. She provides medical care not only through mere treatment but also through communication that emphasizes patient QOL. Using her knowledge and experience as a MD, she has been engaged in the approval review of pharmaceuticals and medical devices at PMDA since 2021.
Hisashi MiyazakiSpecial Advisor, Life Science Innovation Network Japan (LINK-J)
Prior to joining LINK-J when the organization was established in 2016, Mr. Miyazaki served the government mainly at Ministry of Health, Labour and Welfare (MHLW) and then experienced public affairs roles in pharmaceutical industry.
Mari Sakuramotocotree Inc.
Graduated from Kyoto university, worked at Morgan Stanley and Goldman Sachs as an equity analyst. Founder and CEO of cotree, Inc (2014- ) which is a Japanese pioneer of web-based psychotherapy, and CoachEd, Inc (2020-) which provides intensive coaching program for leaders. External board director of CAMPFIRE, Inc.
Jingqing ZhangPangaea Data Limited/ Head of AI
Jingqing is leading the AI team at Pangaea and working directly with the founders. Jingqing received his BEng degree in Computer Science and Technology from Tsinghua University, 2016 and MRes degree with distinction in Computing from Imperial College London, 2017. His achievements include being awarded National Scholarship of China (top 1%) and being the founder and main contributor of deep learning tools, including TensorLayer 2.0 and PEGASUS during his time at Google Bay Area (California).
Jin WatanebePresident & CEO（physical therapist）, Bestreha, Inc.
After acquisition of a physiochemist, he engaged in visiting rehabilitation and day service, and established Sea Life Co., Ltd as Our predecessor company in February 2008, in Nagoya City, Aichi Prefecture and became a representative director. After that, he suspended Sea Life Co., Ltd. and engaged in the day service business of Best Care Co., Ltd..
In May 2011, He resumed our business and became the representative director. In addition, the company name was changed to Best Reha Co., Ltd. and moved to Tokyo. Currently, he is also the Vice President of the Day Service Association.
Masashi OmuroOmuro Occupational physician office
After graduating from University of Environmental Health, He completed clinical training at Omori Red Cross Hospital in 2007. Between 2007 and 2009, he studied the practice of occupational physicians and was conducting research on preventive medicine at Occupational Health Training Center.
In 2009, He was an occupational physician of Johnson & Johnson k.k.
In 2014, He joined Doyukai medical corporation.
Currently, he is an medical adviser to 30 companies as an Occupational physician.
Katsuya HisamichiShimokitazawa Hospital CEO
Graduated Dokkyo Medical University, Japan (Dermatology Department). From 1993 - 2010
Staff Dermatologist at Juntendo University Hospital (Tokyo, Japan). From 2007 - 2010
Visiting Assistant Professor of John Hopkins School Of Medicine (USA).
From 2009 - 2010
Senior Manager of the R&D Department of Galderma company, under Nestlé Skin Health
Miki NagayamaAssistant Manager
Delivery Coordination DEPT.
Aflac Life Insurance Japan Ltd.
Tomoya WadaExective Director of Corporate Planning Department, ARCADIA SYSTEMS Inc.
Graduated from Kansai University in 2005 and worked for a mail-order company for 12 years. In 2017, joined the current company (ARCADIA SYSTEMS Inc.) .
At the current company, launched multiple projects such as system development of “DIEMAS”: which may enable to save dialysis patients lives at the time of disaster by efficiently and quickly collecting the information of dialysis facilities operating status.
In June of this year, developed a system “VAMCS”: which enables to match the unexpired surplus vaccine for COVID-19 with those who wish to vaccinate as soon as possible when other’s reservation are cancelled. Also developed a system which visualizes the availability of the PCR tests at the remote laboratories and enables to easily request tests to the laboratories when the tests capacity is likely to exceed the limit.
Toryo ItoCEO, InTrip
Yuki NaruseCEO, InTrip
Gomi HayakawaILLUMINATE Inc.
CEO of ILLUMINATE Inc. Born in Tokyo in 1995. Founded the lingerie brand “feast” and the dress brand “Double Chaka” while attending Tama Art University, selling them mainly on e-commerce platforms. Launched and continuing working on ILLUMINATE, a project to broaden women's choices, including those related to menstruation, in 2019.
Kuniaki TanitsuMitsui Fudosan Co.,Ltd.
Executive Manager, Planning Group Kashiwanoha Urban Planning and Development Department
Kashiwa-no-ha Omics Gate Secretary-General
Kuniaki Tanitsu graduated from Hitotsubashi University in 1990 with a Bachelor's Degree in faculty of commerce. After working in the Leasing and Marketing Department in the Office Building Division of Mitsui Fudosan Co., Ltd., he was appointed as an Executive Manager of the Planning Group of Kashiwanoha Urban Planning and Development Department in 2019. He is also in charge of a Secretary-General of Kashiwa-no-ha Omics Gate since April, 2019.
Chieko NishiyamaDirector＆COO, Antaa, Inc.
Tokyo Medical and Dental University, Visiting Assistant Professor
Chieko Nishiyama started her career at Recruit Inc. She encountered Antaa while working at Deloitte Tohmatsu Venture Support Co., Ltd., where she supported hundreds of start-ups through the Tokyo Prefectural government-funded Aoyama Startup Acceleration Center. In 2018 she joined Antaa Inc. The company’s mission is “Connecting doctors, saving lives”; it is currently developing multiple online services which enable doctors to share medical knowledge. In 2020, as COO, she contributed to the successful streaming of over 300 videos. In 2021 she developed and released “Antaa Slide,” which has become one of the leading slide sharing services in Japan. In August of 2021 Antaa joined the JMDC group. Access to JMDC’s extensive health data will allow Antaa to more effectively achieve its corporate mission.
Naoki OkamuraAstellas Pharma Inc.
Representative Director, Executive Vice President, Chief Strategy Officer and Chief Financial Officer, Chief Business Officer
Naoki Okamura, after graduating from the Faculty of Pharmacy, University of Tokyo, joined Yamanouchi Pharmaceutical Co. Ltd. (currently Astellas Pharma Inc.) in 1986. He was involved in corporate planning and business development. In 2012, he was assigned Senior Vice President, Chief Strategy Officer at Astellas Pharma Europe Ltd. After returning to Astellas Pharma Inc., he held various posts, such as Vice President of Business Development, Vice President of Corporate Planning and Chief Strategy Officer. In April 2018, he took the lead in the establishment of Rx+ Business Accelerator and the formulation of Corporate Strategic Plan 2018 that was being developed concurrently. Since June 2019, he has been serving as Representative Director, Corporate Executive Vice President and Chief Strategy Officer. Currently, he also holds the position of Chief Financial Officer and Chief Business Officer.
Kohei HirakoAssistant Professor Frontier, Science and Social Co-creation Initiative, Kanazawa University
Kensuke JojiChief Executive Officer, Jolly Good Inc.
Kensuke has 20 years of experience in advanced technology business development at TV stations and advertising companies.
In 2011, he moved to Los Angeles where he managed new business development in North America and Asian countries.
After coming back to Japan, Kensuke founded Jolly Good Inc in 2014 and in 2015, launched GuruVR, a high-precision VR lab, which became the top market share in the TV industry.
In 2018, Kensuke announced VR x AI human resource development solution, and in 2019, announced medical education VR, social skills training VR, and nursing care education VR, leading the use of VR in the medical and welfare industry.
In 2020, he announced a digital treatment VR business for mental illness and succeeded in raising a total of 2.2 billion yen in funding.
Specializes in video technology, business development using advanced technology, overseas business development, and corporate management.
Yujiro OtsukaRepresentative, Plusman LLC
Graduated from the Department of Industrial and Mechanical Engineering, Faculty of Engineering, University of Tokyo in 2006.
Certified Public Accountant, Full Member of the Japanese Society of Actuaries.
Worked as a life insurance actuary and financial engineering model developer at Milliman Inc., the world's largest actuarial consulting firm.
Started research on medical imaging Deep Learning at the Department of Diagnostic Radiology, Juntendo University School of Medicine in 2017.
Founded Plasman LLC in April 2018, recorded the highest academic research performance with his lung nodule AI "Plus Lung Nodule" and obtained Japanese regulatory clearance.
The company has received multiple regulatory clearances, including the world's first lymph node AI and X-ray AI that supports all imaging findings.
We are deeply involved in everything from academic research to reaching the hands of users.
Yosuke FujimotoEY Japan Health Care Sector Assurance Leader, Ernst & Young ShinNihon LLC
Yosuke Fujimoto, EY Japan Health Care Sector Assurance Leader, provides services to enhance the transparency of companies involved in healthcare infrastructure.
In addition to audits of listed companies, medical institutions and educational and research institutes, he is also engaged in consultancy for various organizations, including local government, medical institutions and pharmaceutical startups.
Yosuke has been a committee member of the Japan Institute of Certified Public Accountants on several occasions. He is also an accomplished author and frequent guest speaker at lectures and seminars.
He is a certified public accountant and a graduate of the Faculty of Economics at Keio University, Japan.
Yumi KawataCEO (M.D, Ph.D), Hedgehog MedTech, Inc.
Yumi Kawata, MD, PhD, is Founder and CEO of Hedgehog MedTech, Inc, a start-up Digital Therapeutics (DTx) company.
Previously, Yumi was a manager with SoftBank Corp, where she evaluated new Healthcare & Life Science investment opportunities, managed relationships with strategic partners. Prior to SoftBank, she was a Government Relations specialist with Medley, Inc, where she built and maintained the relationships with Ministry of Health, Labour and Welfare and Academia. She launched researches and POCs, contributing to the spread of telemedicine in Japan. She also served as a technical officer for MHLW. Yumi was involved in the management of researches on Rare and Intractable diseases and Infectious Diseases.
Yukiko KatoExecutive Officer, General Manager, Corporate Venture Capital Department, SBI Investment Co., Ltd.
Ms. Yukiko Kato has over 19 years of experience in the venture capital business at SBI Investment Co., Ltd.
After engaging in the corporate finance business at ING Securities Investment Banking, joined Biovision Capital Corp. as a bio/healthcare VC at its establishment in 2002 and involved in investment and incubation for venture businesses mainly in the healthcare field. She was transferred to SBI Investment Co., Ltd in 2005 and ever since, has been involoved in investment, incubation in the healthcare and IT field both in Jpana and overseas.
From April 2016, she is engaged in Coporate venture fund management, supporting open innovation.
Member of the Promotion Committee and Member of the Evaluation Committee for Program for Building Regional Innovation Ecosystems of the Ministry of Education, Culture, Sports, Science and Technology.
Makoto OginoRx+ Business Accelerator, Business Producer, Astellas Pharma Inc.
Makoto Ogino joined Yamanouchi Pharmaceutical Co. Ltd. (currently Astellas Pharma Inc.). He was involved in molecular medicine research lab. for new drug target discovery and research of mode of actions of drug and/or candidate chemicals. In 2013, he transferred to the research section of new business. He have involved Rx+ business accelerator from 2019, he has been serving as Business Producer from 2020. He has conducted joint research with numerous universities and bio-related companies, and has been actively involved in collaboration with external partners since joining the company. He has experienced many times that "a little encounter" with an external partner will grow into an important project later, and He thinks that there is a project for today again by making use of its importance. He graduated from the graduate school of pharmaceutical sciences, Tohoku University. PhD. (pharmaceutical sciences) , Pharmacist.
Motohiro KanayamaRx+ Business Accelerator, Business Producer, Astellas Pharma Inc.
Motohiro Kanayama joined Astellas Pharma Inc. in 2009. From 2016, he started the ideation for new business. In 2018, he was assigned Business Producer. Aiming for innovation by interdisciplinary fusion, he is trying to create healthcare solutions by fusing knowledge related to health behavior such as exercise, knowledge related to behavioral change such as gamification, and scientific knowledge. Examples of efforts include the exercise support service "Fit-eNce", collaboration with BANDAI NAMCO Entertainment Inc., and "Health Mock Lab." which was established with Yokohama City University and Tokyo University of the Arts.
Akiko HayakawaRx+ Business Accelerator, Business Producer, Astellas Pharma Inc.
Akiko Hayakawa, after graduating from Graduate School of Pharmaceutical Sciences & Faculty of Pharmaceutical Sciences, Tohoku University, joined Astellas Pharma Inc. in 2008. She was involved in Metabolic syndrome and Neuroscience research PJs in the department of pharmacology in Tsukuba. From 2015, she joined new business incubation activity, and from 2018, belongs to Rx+ Business Accelerator. Her theme is to realize patient centricity through needs-driven business creation.
Katsuya YonezuPharmaEssentia Japan KK/General Manager & Head, Japan Operation
Work experience: Joined Yamanouchi Pharmaceutical Co., Ltd. (currently Astellas Pharma Inc.) in 1995. Since then, has experienced mainly marketing positions for medical drugs at Janssen Pharma, Novartis Pharma, and Shire Japan. Since March 2017, Joined PharmaEssentia in current position to launch and manage a Japan subsidiary. Leading strategy planning and execution. Currently, he is conducting domestic clinical trials and regulatory application work, aiming to obtain new drug approval in Japan.
Education: Graduated from the University of Wales School of Business (MBA), Kochi University Faculty of Science (Biology)
Learned teamwork and leadership from rowing he engaged in through students to adults.
Born in 1971, from Otsu City, Shiga Prefecture.
Mariko MabuchiSenior Analyst, Fisco, Inc. /Equity CrowdFunding Analyst, JCC, Inc.
Ms.Mabuchi graduated from the Kyoto University of Government in 2011. She manages the assets of medical corporations as a trader. After that, she changed jobs to an analyst at FISCO Inc. She also works for JCC Inc, which helps startup raise money as Equity Crowd Funding Analys and marketing.
Katsuya Tsuchihara, M.D.,Ph.D.National Cancer Center Japan
Chief, Division of Translational Informatics
Exploratory Oncology Research & Clinical Trial Center
Dr. Katsuya Tsuchihara graduated from Kanazawa University School of Medicine in 1993 (M.D.) and Tokyo Medical and Dental University in 2000 (Ph.D.). After working at the Ontario Cancer Institute at the University of Toronto, he was appointed Head of the Research Center for Innovative Oncology at the National Cancer Center Hospital East in 2005 and Chief of the Exploratory Oncology Research and Clinical Trial Center at the National Cancer Center in 2013. He is also a visiting professor at the University of Tokyo Graduate School of Frontier Sciences and the Tokyo University of Science Graduate School of Biological Sciences. He is engaged in translational research that links basic research to clinical practice. He aims to create a Japan-originated research and development platform that can meet the needs of more holistic and individualized cancer treatment.
Richard CassidyAstellas Pharma Inc.
Senior Vice President, Rx+ Business Accelerator
Richard Cassidy and his team are collaborating with innovators to develop business opportunities in healthcare that will bring value to patients through non-pharmaceutical products and solutions. Richard has a Chemical Engineering degree from the University of Edinburgh and across more than 20 years, he has worked in Pharma, Diagnostics, Med Tech and at a software start-up, giving him a unique and useful perspective as all of these areas rapidly converge.
Richard joined Astellas in 2009 where he has been responsible for Corporate Strategy in the EMEA region, globally from the Japan HQ and most recently headed up Operations and Commercialisation for Astellas' cell-based therapy activities near Boston. If you're passionate about improving value for patients, he'd love to talk to you.
Takuya BabaSocial Welfare Coporation AIKAWA-SHUNJUKAI / Executive Director
After graduating from university, he worked for a foreign-affiliated company before assuming his current position in 2010. The wall that separated the nursing care facility from the community was demolished to create a garden that can be accessed by local residents at any time. We jointly developed a system called "CareCollabo" that connects resident families and nursing care sites using ICT. Opened Kamiyato Nursery School plus, where 0-18 year olds can spend time together regardless of their disabilities. In the spring of 2022, the Kasugadai Center Center, a cultural center for coexistence with the local community, will be opened on the site of a hollowed-out shopping district. He is the author of "Human Resources Acquisition Strategy for the Long-term Care Industry (Gentosha 2015)", co-authored "My Body Doesn't Stay (Kawade Shobo Shinsha 2020)", and "Care to Break Walls Create a City That Cares About Each Other (Iwanami Shoten 2021)".
Satoko ShizaiVP, Head of Digital and IT Supervisory Division, Chugai Pharmaceutical Co., Ltd.
Joined IBM Japan in 1986.
After serving as General Manager of the Public Agency System Division and the Software Division, Satoko was assigned to IBM Corporation in New York, and upon returning to Japan in 2009, she was appointed Vice President in charge of Security Business and Public Utilities. In 2019, she joined Chugai as the company’s first woman Vice President. “We aim to become a top innovator in the healthcare industry by collaborating with external partners and digital talents.
Nobuya IshiiHead of Science & Technology Intelligence Dept., Project Lyfecycle Management Unit, Chugai Pharmaceutical. Co., Ltd.
Head of Science & Technology Intelligence Dept., Project Lifecycle Management Unit, Chugai Pharmaceutical Co., Ltd.. Ph.D. (Pharmacy). After finishing Graduate School of Pharmaceutical Sciences in Okayama University in 1992, I joined to Nippon Roche Reseach Center as a rerseacher and participated to drug discovery research until 2016 even after moving to Chugai due to a strategic alliance between Roche and Chugai . During this time, I was dispatched to Roche Center for Medical Genetics in Roche Basel in 2002 to conduct biomarker reseach. After moveing to Project Lifecycle Management Unit, I surved as a global project leader in oncology and an R&D network manager, I have been in my current position since 2017. I am working on creating an environment for utilizing external innovation and promoting personalized healthcare.
Lia CamargoGlobal Business Manager, fermata Inc.
Lia is a bilingual project manager and translator with experience supporting the growth of early stage startups, with roots in Japan, the United States, South Korea and Colombia. She has a B.A. in Women's and Gender Studies from Wellesley College (Massachusetts, USA), and is passionate about sexual and reproductive health and rights. Previously, at a coworking space and accelerator program based in Boston, she facilitated R&D collaboration between U.S.-based startups and multinational corporations focusing on biotechnological innovation. Lia currently manages global partnerships at Tokyo- and Singapore-based fermata inc., a one-stop market entry facilitator and femtech industry hub.
Motofumi SogoProfessor, Osaka University, Graduate School of Dentistry
Keiko KodaCEO, AsMama, Inc.
Kensuke YoshimuraRepresentative Director, Association for Health and Medical Literacy Promotion
Dr.Yoshimura graduated from Chiba university School of medicine.
He got MPH degree from Tokyo University and Ph.D from Chiba University.
2015-2018 He worked a ministry of health,labour and welfare.
2019- Chiba University Hospital, Center for Nextgeneration of Community Health. Director.
2021- COVID-19 Vaccine Awareness Project : Cov-Navi,Director.
Kota Hada
Yuya TakakuCEO, Sportip,Inc
Yuya Takaku graduated from the School of Physical Education, Health & Sport Sciences, University of Tsukuba in 2018. He completed the Graduate School of Business Administration, Hitotsubashi University. While studying University of Tsukuba, he studied a wide range of Health & Sport Sciences such as a research on sports management in the area of fitness and activities to popularize parasports in Cambodia. He founded the startup company, Sportip Inc, based on the experience that he had to give up playing baseball due to a injury. He was selected for Forbes 30 UNDER 30 JAPAN 2021.
Yukari TsunodaCEO vivola Co., Ltd.
Ms. Tsunoda, the president of vivola Corporation, graduated from the Graduate School of Science and Engineering, Tokyo Institute of Technology and joined Sony Corporation in 2009 as a research and development professional.Our company was founded in May 2020 with the business domain of women's healthcare x AI.In the early stages, we are developing services in the area of infertility treatment, which is my own original experience.
Moyuru IinagaChief of Family research laboratory, Connehito corporation
Joined Conehito Co., Ltd. in 2021 and became the cheif of the Family Research Lab.
I carry out a survey on families from more than 10,000 families every year and publish a report.
In order to creat a society that every family can realize their ideal family, I am also charged of PR using data related to families, including surveys, with the aim of raising interests in families in the world.
Hidekazu YokoyamaBiz Lead. Med-DX Dept. MICIN, Inc.
Hidekazu graduated from Keio university and joined M3, Inc. in 2010 as the first new graduate and engaged in marketing support for pharmaceutical companies. While leading the conclusion and execution of strategic and comprehensive alliances with multiple pharmaceutical companies, he became involved in increasing the value of investee startups. He joined MICIN and is currently leading business development with pharmaceutical companies utilizing MICIN's platform.
Simon HarrisSenior Project Manager, Kheiron Medical Technologies
Simon has over 20 years of experience running complex and transformative projects within the NHS and leads Kheiron's largest programme - the AI in Health & Care Award. Passionate about improving patient care and utilising technology as an enabler for change; he has a detailed knowledge and understanding of all aspects of healthcare within the UK. Before joining Kheiron he was the Senior Project Manager within a regional NHS imaging network. He oversaw the successful deployment of a shared PACS and RIS system across 7 NHS Trusts. This facilitated completely new ways of working and image sharing meaning that a patient could be scanned at one hospital and have their image reported by a specialist hundreds of miles away within minutes. "I feel honoured and privileged to work at Kheiron. Our mission to give every woman a better fighting chance against breast cancer through the power of AI is phenomenal."
Dr Satish Prasad RathPhysician-Scientist, Inventor, VC, Adj Faculty Digital Health
